John E. Sagartz, DVM, PhD, DACVP John E. Sagartz, DVM, PhD, DACVP Bioanalytical Systems, Inc. WEST LAFAYETTE, Ind., July 09, 2018 (GLOBE NEWSWIRE) — Bioanalytical Systems, Inc. (NASDAQ:BASI) has announced that its Board of Directors agreed unanimously on July 2, 2018, to appoint John E. Sagartz, DVM, PhD, DACVP, as a director. “We’re delighted to welcome John... Read more
WEST LAFAYETTE, Ind., July 02, 2018 (GLOBE NEWSWIRE) — Bioanalytical Systems, Inc. (NASDAQ:BASI) and Seventh Wave Laboratories, LLC, today announced that they have signed an asset purchase agreement (APA) joining operations to provide broader solutions and greater scientific expertise to clients. BASi provides contract research services and niche instrumentation to the life sciences industry, primarily in drug research, discovery,... Read more
https://www.basinc.com/assets/file_uploads/BASi%20Baim_Bourdage%20PR-Final.pdf Read more
PRESS RELEASE UPDATED: AUG 3, 2017 08:33 EDT WEST LAFAYETTE, IN, August 3, 2017 (Newswire.com) – Bioanalytical Systems, Inc. (NASDAQ: BASI) (“BASi” or the “Company”) today announced that its Board of Directors unanimously elected R. Matthew Neff, as a director, effective August 1, 2017. “We are pleased to welcome Mr. Neff to the Board and look forward to... Read more
PRESS RELEASE UPDATED: JUN 27, 2017 08:41 EDT WEST LAFAYETTE, IN, June 27, 2017 (Newswire.com) – Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced that it has successfully completed the refinancing of its existing senior secured credit facility with a new senior secured credit facility, consisting of a $4.5 million term loan and... Read more
PRESS RELEASE UPDATED: JUN 20, 2017 WEST LAFAYETTE, IN, June 20, 2017 (Newswire.com) – Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced that the board of directors unanimously elected Dr. Gregory C. Davis as a director effective June 14, 2017. This action brings the number of directors to four. Larry Boulet, BASi’s Chairman... Read more
WEST LAFAYETTE, Ind., June 7, 2017 – Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced its “SEND” compliance with a fully integrated software solution for streamlining data management and reporting. In partnership with PDS Life Sciences (PDS), BASi has validated TranSEND™, a submission solution that allows for the creation of reliable and accurate... Read more
FOR MORE INFORMATION: Company Contact: Jill Blumhoff Chief Financial Officer & Vice President of Finance Phone: 765.497.8381 jblumhoff@BASinc.com WEST LAFAYETTE, IN, May 1, 2017 — Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced its Board of Directors has appointed Dr. Peter T. Kissinger, founder and former Executive Chairman and CEO of BASi, as... Read more
FOR MORE INFORMATION: Company Contact: Jill Blumhoff Chief Financial Officer & Vice President of Finance Phone: 765.497.8381 jblumhoff@BASinc.com WEST LAFAYETTE, IN, March 8, 2017 — Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced that Philip A. Downing has been promoted to Senior Vice President, Preclinical Services. “ “Philip has demonstrated the ability to... Read more